Landscapes / Targets
cereblon
5 drugs act on cereblon, in 22 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs5
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | 16 Nov 2027Phase 3 trial completes | |||
| Next date | 16 Nov 2027 · Phase 3 trial completes | ||||
| Also tested for | Multiple Myeloma, Lymphoma, B-Cell | ||||
| Open drug page | |||||
— |
Phase 3 | 30 Nov 2026soonPhase 1/2 trial completes | |||
| Next date | 30 Nov 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Multiple Myeloma, Relapsed or Refractory Multiple Myeloma | ||||
| Open drug page | |||||
— |
Phase 3 | 7 Apr 2027Phase 1/2 trial completes | |||
| Next date | 7 Apr 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Lymphoma, Non-Hodgkin, Lymphoma, B-Cell and 6 more | ||||
| Open drug page | |||||
F182112not checked |
— |
Phase 3 | 20 May 2028Phase 2 trial completes | ||
| Next date | 20 May 2028 · Phase 2 trial completes | ||||
| Also tested for | Relapsed or Refractory Multiple Myeloma, Relapsed or Refractory Multiple Myeloma (RRMM) and 1 more | ||||
| Open drug page | |||||
STAR-LLDnot checked |
— |
Phase 1/2 | 31 May 2027Phase 1/2 trial completes | ||
| Next date | 31 May 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Multiple Myeloma | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 3 of 5 drugs. The other 2 are marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026